This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignees: Dartmouth College, Rutgers, The State University of New Jersey, The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 708 
1 out of 1,496 
1 out of 3,696 
Years Active: 2014
Title: Damian Medici: Innovator in Synthetic Triterpenoids
Introduction
Damian Medici is a notable inventor based in Boston, MA (US). He has made significant contributions to the field of biotechnology, particularly in the treatment of bone and cartilage diseases. His innovative approach utilizes synthetic triterpenoids, showcasing his commitment to advancing medical science.
Latest Patents
Damian Medici holds a patent titled "Methods for using synthetic triterpenoids in the treatment of bone or cartilage diseases or conditions." This invention features the use of a synthetic triterpenoid to induce gene expression and differentiation of stem or progenitor cells in the treatment of bone and cartilage diseases or conditions. He has 1 patent to his name, reflecting his focused research and development efforts.
Career Highlights
Throughout his career, Damian has worked with prestigious institutions such as Dartmouth College and Rutgers, The State University of New Jersey. His work in these environments has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Some of his notable coworkers include Michael B. Sporn and Karen T. Liby. Their collaborative efforts have furthered the understanding and application of synthetic triterpenoids in medical treatments.
Conclusion
Damian Medici's innovative work in synthetic triterpenoids represents a significant advancement in the treatment of bone and cartilage diseases. His contributions to biotechnology continue to inspire future research and development in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile